Legal Assistance for Biotech Expansion and Funding Success

Our firm provided comprehensive legal counsel to a leading Chinese specializing in cell and gene therapy. We assisted in the registration of their subsidiary, ensuring full compliance with all regulatory requirements and facilitating a smooth establishment process.

Additionally, we advised the company on successfully closing a significant Series C+ funding round, securing over 100 million RMB. This landmark investment strengthens their position as a frontrunner in gene therapy delivery.

The client offers economical, reliable, and scalable viral and non-viral vector solutions, including platforms for plasmid DNA, AAV, lentivirus, and mRNA manufacturing. Their services support programs from early-stage R&D and preclinical development through to clinical trials.

Our legal support encompassed corporate structuring, regulatory compliance, and transaction advisory, contributing to their continued growth and success in the biotech industry.